Ceredex Value Advisors LLC bought a new position in Medical Properties Trust (NYSE:MPW) in the 1st quarter, Holdings Channel reports. The institutional investor bought 5,040,677 shares of the real estate investment trust’s stock, valued at approximately $66,789,000.
A number of other institutional investors and hedge funds also recently bought and sold shares of MPW. Creative Planning lifted its holdings in Medical Properties Trust by 114.8% in the 4th quarter. Creative Planning now owns 65,052 shares of the real estate investment trust’s stock worth $896,000 after purchasing an additional 34,762 shares during the last quarter. Schwab Charles Investment Management Inc. lifted its holdings in Medical Properties Trust by 7.9% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 2,023,941 shares of the real estate investment trust’s stock worth $27,890,000 after purchasing an additional 148,707 shares during the last quarter. State of Alaska Department of Revenue lifted its holdings in Medical Properties Trust by 11.7% in the 4th quarter. State of Alaska Department of Revenue now owns 219,090 shares of the real estate investment trust’s stock worth $3,017,000 after purchasing an additional 22,880 shares during the last quarter. Strs Ohio lifted its holdings in Medical Properties Trust by 3.4% in the 4th quarter. Strs Ohio now owns 471,291 shares of the real estate investment trust’s stock worth $6,494,000 after purchasing an additional 15,709 shares during the last quarter. Finally, Northpointe Capital LLC acquired a new stake in Medical Properties Trust in the 4th quarter worth approximately $3,291,000. Hedge funds and other institutional investors own 80.15% of the company’s stock.
Several research analysts have commented on the company. Zacks Investment Research downgraded Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Wednesday, April 18th. Deutsche Bank dropped their price target on Medical Properties Trust from $13.50 to $13.00 and set a “hold” rating on the stock in a research report on Monday, March 19th. Finally, ValuEngine downgraded Medical Properties Trust from a “buy” rating to a “hold” rating in a research report on Monday, April 2nd. Eight research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $14.28.
Shares of NYSE MPW opened at $13.08 on Friday. The company has a market capitalization of $4.80 billion, a price-to-earnings ratio of 9.69, a price-to-earnings-growth ratio of 2.47 and a beta of 0.69. The company has a current ratio of 2.04, a quick ratio of 2.04 and a debt-to-equity ratio of 1.27. Medical Properties Trust has a 12 month low of $13.15 and a 12 month high of $13.31.
Medical Properties Trust (NYSE:MPW) last released its quarterly earnings data on Thursday, May 3rd. The real estate investment trust reported $0.25 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.11). The firm had revenue of $205.05 million for the quarter, compared to the consensus estimate of $204.70 million. Medical Properties Trust had a net margin of 41.47% and a return on equity of 8.14%. The business’s revenue for the quarter was up 31.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.33 earnings per share. research analysts forecast that Medical Properties Trust will post 1.43 earnings per share for the current fiscal year.
In other news, Chairman Edward K. Aldag, Jr. sold 116,216 shares of the business’s stock in a transaction that occurred on Tuesday, March 27th. The stock was sold at an average price of $12.56, for a total transaction of $1,459,672.96. Following the sale, the chairman now directly owns 1,759,620 shares in the company, valued at $22,100,827.20. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.00% of the company’s stock.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust (NYSE:MPW).
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.